Toxicology – Antidote: Glucagon for Beta-Blocker Poisoning

Indication

Glucagon may be used in beta-blocker overdose, particularly when significant bradycardia, hypotension, or reduced cardiac contractility is present.

Mechanism of Action

Normally, stimulation of cardiac beta receptors activates a G protein, which stimulates adenylyl cyclase. This increases cAMP, activates protein kinase A, increases calcium entry into cardiac cells, and improves heart rate and contractility.

In beta-blocker poisoning, this pathway is blocked at the beta receptor. Glucagon can bypass the blocked receptor by activating its own receptor and stimulating adenylyl cyclase through a separate pathway.

This leads to:

• Increased cAMP
• Increased intracellular calcium
• Improved cardiac contractility
• Increased heart rate

A useful way to remember this is that glucagon activates adenylyl cyclase through a “backdoor” pathway that does not depend on beta receptors.

Administration

Glucagon is given intravenously, often as an initial bolus followed by a continuous infusion if the patient responds.

Because relatively large doses may be required in toxicologic emergencies, treatment should be directed by a poison center or medical toxicologist.

Adverse Effects

The most common adverse effect is:

• Nausea and vomiting

Antiemetic therapy may therefore be useful. Hyperglycemia can also occur.

Key Points

• Glucagon can bypass beta-receptor blockade and increase intracellular cAMP.
• It may improve bradycardia and myocardial contractility in beta-blocker poisoning.
• Vomiting is common after administration.
• In severe beta-blocker toxicity, glucagon is usually one part of a broader resuscitation strategy that may also include vasopressors and hyperinsulinemic euglycemia therapy.

Toxicology – Antidote: Hyperinsulinemic Euglycemia (HIE) Therapy

Indications

Hyperinsulinemic euglycemia therapy is used for severe calcium channel blocker (CCB) and beta-blocker poisoning, especially when there is significant myocardial depression, hypotension, or shock.

Mechanism of Action

In severe CCB and beta-blocker toxicity, the heart becomes less able to use its usual fatty-acid energy pathway and relies more heavily on glucose.

High-dose insulin helps by:

• Increasing myocardial glucose uptake
• Improving cellular energy production
• Producing a positive inotropic effect
• Improving cardiac contractility and circulation

In calcium channel blocker overdose, pancreatic insulin release may also be suppressed, producing hyperglycemia with relative hypoinsulinemia.

Administration

HIE therapy uses high-dose IV insulin together with glucose supplementation as needed to maintain normal blood glucose.

Treatment typically involves:

• An initial IV insulin dose
• A continuous high-dose insulin infusion
• Dextrose supplementation when necessary
• Gradual adjustment based on blood pressure, cardiac function, and metabolic response

Because this therapy uses insulin doses far above those used routinely for diabetes, it should be managed in a closely monitored critical-care setting.

Monitoring

Frequent laboratory and bedside monitoring is essential, especially:

• Blood glucose
• Potassium
• Other electrolytes
• Blood pressure
• Heart rate and rhythm
• Cardiac perfusion and overall hemodynamic response

Major Risks

The most important complications are:

• Hypoglycemia
• Hypokalemia

Both require active monitoring and correction during therapy.

Key Points

• HIE is an important treatment for severe CCB and beta-blocker toxicity.
• Its main benefit is improved myocardial energy utilization and contractility.
• CCB poisoning often causes hyperglycemia because calcium-channel blockade reduces pancreatic insulin secretion.
• A useful memory aid is that the poisoned myocardium is energy-starved and benefits from increased glucose utilization.
• HIE should be performed with intensive glucose, electrolyte, and cardiovascular monitoring.

Toxicology – Antidotes: Chelating Agents

Overview

Chelators bind specific toxic metals and form complexes that can be eliminated from the body, usually through the urine. The appropriate agent depends on the metal involved and the severity of poisoning.

Succimer (DMSA)

Binds: Lead, arsenic, and mercury.

Mechanism of Action

• Water-soluble compound related to dimercaprol (BAL)
• Contains sulfhydryl groups that bind toxic metals
• The resulting complexes are primarily excreted in urine
• Has only limited effectiveness for cadmium removal

Succimer is commonly used as an oral chelator, particularly for selected cases of lead poisoning.

DMPS (2,3-Dimercapto-1-Propanesulfonic Acid)

Binds: Mercury and arsenic; it can also bind lead.

Mechanism of Action

• Water-soluble dimercaprol-related chelator
• Sulfur-containing groups bind metal ions
• Metal-chelator complexes are eliminated mainly through the kidneys

Availability and approved indications vary by country.

Penicillamine

Binds: Primarily copper; it has also been used in selected cases involving other metals.

Mechanism of Action

• A penicillin-related compound without antibacterial activity
• Acts as a thiol-containing chelator
• Binds free copper and reduces its ability to participate in damaging oxidation-reduction reactions
• Excreted in urine

It is particularly associated with treatment of copper overload, including Wilson disease.

Calcium Disodium EDTA (CaNa₂EDTA)

Binds: Lead.

Mechanism of Action

• Primarily acts in the extracellular compartment
• Binds circulating lead and promotes its urinary elimination
• As circulating lead decreases, additional lead can redistribute from tissues into the blood and become available for chelation

The calcium disodium form is used for lead poisoning; plain disodium EDTA can cause dangerous hypocalcemia.

Deferoxamine (DFO)

Binds: Iron.

Mechanism of Action

• Chelates free ferric iron
• Forms the water-soluble complex ferrioxamine
• Mainly targets free or loosely bound iron rather than iron incorporated into hemoglobin
• The complex is eliminated through urine

Deferoxamine is an important antidote for significant acute iron poisoning.

Dimercaprol (BAL – British Anti-Lewisite)

Binds: Arsenic, mercury, and lead; historically developed for the arsenical warfare agent Lewisite.

Mechanism of Action

• Contains sulfhydryl (–SH) groups that bind toxic metals
• Prevents metals from interacting with sulfhydryl-containing cellular proteins
• Metal-chelator complexes are eliminated primarily through urine

Key Points

• Lead: Succimer or CaNa₂EDTA; dimercaprol may be added in severe cases.
• Arsenic/Mercury: Dimercaprol, succimer, or other specialist-selected thiol chelators.
• Copper: Penicillamine.
• Iron: Deferoxamine.
• Chelation should be guided by the specific metal, blood concentration, clinical severity, and toxicology consultation.

Toxicology – Antidote: Intravenous Lipid Emulsion (ILE)

Indications

Intravenous lipid emulsion may be considered as a rescue therapy for severe cardiovascular toxicity caused by highly lipophilic drugs, particularly when standard resuscitative measures are failing.

The strongest evidence is for local anesthetic systemic toxicity, especially with agents such as bupivacaine. It has also been used in selected severe poisonings involving drugs such as:

• Tricyclic antidepressants
• Calcium channel blockers
• Beta-blockers
• Bupropion
• Lamotrigine
• Some antipsychotics and other lipophilic toxins

Its use outside local anesthetic toxicity is generally based on case reports and specialist toxicology judgment.

Mechanism of Action

The exact mechanism is not fully established. Proposed effects include:

• Lipid shuttle/sink effect: Lipophilic toxins redistribute from target tissues into the intravascular lipid phase, potentially reducing drug availability at the heart and other organs.
• Metabolic support: Fatty acids may provide an additional energy source for cardiac muscle and improve myocardial performance.

Administration

A 20% lipid emulsion is typically used. Exact dosing depends on the clinical situation and local toxicology protocols, and treatment should ideally be guided by a medical toxicologist or poison center.

Management Considerations

ILE is generally reserved for:

• Severe hypotension
• Malignant dysrhythmias
• Cardiovascular collapse
• Cardiac arrest associated with a suspected lipophilic toxin

It should be used alongside standard airway management, cardiac monitoring, and advanced resuscitative care rather than as a replacement for them.

Risks

Potential complications include:

• Hypertriglyceridemia
• Pancreatitis
• Interference with laboratory testing
• Pulmonary complications
• Thrombosis or impaired microcirculatory flow with very large lipid loads

Key Points

• ILE is best established for severe local anesthetic systemic toxicity.
• Evidence for many other poisonings is limited and often case-based.
• It is generally considered a rescue therapy, not first-line treatment for most overdoses.
• Specialist toxicology consultation is strongly recommended when considering its use.

Toxicology – Antidotes for Toxic Alcohols: Fomepizole, Ethanol & Hemodialysis

Metabolic Pathways

Methanol and ethylene glycol become dangerous mainly after they are metabolized by alcohol dehydrogenase (ADH) into toxic metabolites.

• Methanol → formaldehyde → formic acid
• Ethylene glycol → glycolaldehyde → glycolic acid → glyoxylic acid → oxalic acid
• Ethanol → acetaldehyde → acetic acid

Ethanol

Ethanol has a higher affinity for ADH than methanol or ethylene glycol. By occupying the enzyme, it slows formation of their toxic metabolites and allows more of the parent alcohol to be eliminated unchanged.

Disadvantages include:

• CNS depression
• Nausea and vomiting
• Hypoglycemia
• Need for frequent serum concentration monitoring

Because of these limitations, ethanol is generally less convenient than fomepizole.

Fomepizole

Fomepizole directly inhibits alcohol dehydrogenase, preventing methanol and ethylene glycol from being converted into their harmful metabolites.

Advantages include:

• Predictable dosing
• Less CNS depression than ethanol
• No need to maintain an intoxicating serum alcohol concentration
• Can be used together with hemodialysis when necessary

Possible adverse effects include:

• Headache
• Nausea
• Dizziness
• Drowsiness
• Altered taste
• IV-site irritation

Hemodialysis

Hemodialysis can rapidly remove both the parent toxic alcohol and important toxic metabolites.

It may be needed in severe poisoning associated with:

• Significant metabolic acidosis
• Kidney failure
• Severe clinical deterioration
• High toxic-alcohol concentrations
• Visual symptoms in methanol poisoning

In ethylene glycol poisoning, dialysis is particularly useful when kidney injury or severe acidosis develops.

In methanol poisoning, dialysis removes both methanol and formate, the metabolite responsible for much of its ocular and systemic toxicity.

Additional Supportive Therapy

For ethylene glycol toxicity:

• Thiamine and pyridoxine may help direct metabolism toward less toxic products

For methanol toxicity:

• Folate or folinic acid may enhance metabolism of formate into less harmful compounds

Key Points

• Fomepizole is the preferred ADH inhibitor in most toxic alcohol poisonings.
• Ethanol works by competing for alcohol dehydrogenase but requires close monitoring and causes more adverse effects.
• Hemodialysis is used for severe methanol or ethylene glycol poisoning, especially with major acidosis or organ dysfunction.
• The major goal of antidotal therapy is to prevent formation of toxic metabolites, not simply to remove the parent alcohol.

Toxicology – Antidotes for Cyanide Poisoning

Indications

Cyanide poisoning should be suspected in patients with severe smoke inhalation or occupational exposure who develop findings such as:

• Altered mental status
• Dyspnea
• Seizures
• Coma
• Cardiovascular collapse
• Severe tissue hypoxia and lactic acidosis

Because confirmatory testing is often too slow to guide emergency care, treatment may need to begin based on the clinical picture.

Hydroxocobalamin

Hydroxocobalamin is generally the preferred antidote, especially in smoke-inhalation cases.

Mechanism

• Contains a cobalt atom that binds cyanide
• Forms cyanocobalamin (vitamin B12)
• The resulting compound is then eliminated by the kidneys

Advantages

• Does not induce methemoglobinemia
• Can be used when concurrent carbon monoxide poisoning is suspected
• Does not typically cause significant hypotension

Adverse Effects

• Red discoloration of the skin
• Red urine (chromaturia)
• Headache
• Nausea or vomiting
• Itching

Sodium Thiosulfate

Sodium thiosulfate provides sulfur that the enzyme rhodanese uses to convert cyanide into the much less toxic compound thiocyanate, which is eliminated through the kidneys.

It can be used in smoke-inhalation patients because it does not create methemoglobinemia.

Possible adverse effects include:

• Nausea
• Vomiting
• Hypotension

Nitrites – Amyl Nitrite and Sodium Nitrite

Nitrites convert normal hemoglobin into methemoglobin. Cyanide preferentially binds to methemoglobin rather than mitochondrial cytochrome oxidase, helping remove cyanide from its cellular target.

However, methemoglobin cannot effectively carry oxygen. For this reason, nitrites are generally avoided or used very cautiously when carbon monoxide poisoning or significant smoke inhalation is also present.

Rapid IV administration of sodium nitrite may also cause:

• Marked vasodilation
• Hypotension
• Tachycardia

Mechanism Summary

Cyanide antidotes work mainly by:

• Binding cyanide directly: hydroxocobalamin
• Enhancing detoxification to thiocyanate: sodium thiosulfate
• Creating an alternative cyanide-binding target: nitrites

Key Points

• Hydroxocobalamin is particularly useful in smoke-inhalation cyanide poisoning.
• Sodium thiosulfate assists the body’s natural cyanide-detoxifying pathway.
• Nitrites induce methemoglobinemia and may worsen oxygen delivery when carbon monoxide poisoning is also present.
• Cyanide treatment should not be delayed in a critically ill patient when the clinical suspicion is high.

Toxicology – Antidote: N-Acetylcysteine (NAC)

Indications

N-acetylcysteine is the primary antidote for acetaminophen (APAP) poisoning and can be given orally or intravenously. It may also be considered in some other toxicologic conditions involving oxidative stress or glutathione depletion.

For a known single acute acetaminophen ingestion, obtain a serum level at least 4 hours after ingestion and interpret it using the Rumack–Matthew nomogram. NAC is indicated when the level falls above the treatment threshold.

Treatment should also be strongly considered when:

• The time of ingestion is unknown
• The acetaminophen level is detectable with uncertain timing
• Liver enzymes, particularly AST/ALT, are elevated in a patient with possible acetaminophen toxicity

If the acetaminophen concentration is undetectable and liver enzymes are normal, clinically important toxicity is less likely.

Mechanism of Action

NAC helps protect the liver through several mechanisms:

• Replenishes glutathione, which detoxifies the reactive acetaminophen metabolite NAPQI
• Can act as a glutathione substitute and antioxidant
• Enhances sulfation pathways involved in acetaminophen metabolism
• After liver injury has already occurred, it may improve tissue oxygen delivery and reduce oxidative and inflammatory damage

Administration

Both oral and IV NAC are effective. IV therapy is often preferred when oral treatment cannot be tolerated or in patients with severe hepatic injury.

Common treatment protocols include:

• Oral NAC: loading dose followed by repeated maintenance doses over an extended course
• IV NAC: typically administered as a multi-stage infusion over approximately 21 hours

Treatment may need to continue beyond the standard protocol if acetaminophen remains detectable or liver injury is still progressing.

Monitoring

During treatment, follow:

• Acetaminophen concentration
• AST and ALT
• INR/coagulation studies
• Renal function
• Clinical signs of hepatic failure

NAC is generally continued until acetaminophen is no longer detectable and hepatic injury is clearly improving.

Adverse Effects

IV NAC can cause anaphylactoid reactions, including flushing, rash, wheezing, or hypotension. These are usually managed by temporarily slowing or stopping the infusion and providing symptomatic treatment before restarting when appropriate.

Key Points

• NAC is most effective when started early, but it can still provide benefit even after liver injury has developed.
• Do not delay treatment when significant acetaminophen poisoning is strongly suspected.
• The Rumack–Matthew nomogram applies only to a known, single, acute ingestion with a known time.
• Continued NAC may be necessary when liver enzymes remain markedly abnormal or acetaminophen is still detectable.

Toxicology – Hydrogen Sulfide Poisoning

Source

Hydrogen sulfide is a toxic gas produced during the breakdown of organic material. It may accumulate in sewers, manure pits, petroleum facilities, paper mills, and other poorly ventilated confined spaces. Because it is heavier than air, it can collect in low-lying areas.

Typical Presentation

Workers in a confined space may suddenly collapse after exposure to hydrogen sulfide. Rescuers who enter without proper respiratory protection can also become rapidly incapacitated.

Clinical Features

Lower-level exposure mainly causes mucous membrane and respiratory irritation, including:

• Runny nose
• Tearing
• Red or irritated eyes
• Headache
• Nausea and vomiting
• Dizziness
• Confusion

More severe exposure can produce:

• Sudden loss of consciousness
• Respiratory failure
• Cardiac dysrhythmias
• Coma
• Death
• Delayed pulmonary edema

Mechanism of Action

Hydrogen sulfide inhibits cytochrome oxidase, disrupting cellular oxygen utilization in a manner similar to cyanide. It also directly irritates the eyes and respiratory tract. At high concentrations, it can cause extremely rapid CNS depression and collapse.

Although hydrogen sulfide has a characteristic rotten-egg odor, prolonged or intense exposure can impair the sense of smell, making odor an unreliable warning sign.

Management

Treatment is mainly supportive:

• Immediate removal from the contaminated environment by appropriately protected rescuers
• Airway and respiratory support
• High-concentration oxygen
• Continuous cardiac monitoring
• Treatment of dysrhythmias and other complications as needed

Specialized therapies such as hyperbaric oxygen or hydroxocobalamin have been considered in severe cases, but supportive resuscitation remains the mainstay of treatment.

Key Points

• Hydrogen sulfide is especially dangerous in confined spaces.
• High concentrations can cause sudden collapse with little warning.
• The rotten-egg smell cannot be relied upon because olfactory fatigue may occur.
• Delayed pulmonary complications can develop even after the initial exposure.

Toxicology – Carbon Monoxide (CO) Poisoning

Source

Carbon monoxide is a colorless, odorless, nonirritating gas produced by incomplete combustion. Common sources include house fires, furnaces, heaters, grills, gasoline-powered generators, and motor vehicle exhaust. Methylene chloride exposure can also produce carbon monoxide after metabolism in the body.

Typical Presentation

Several people from the same household may develop headache, dizziness, nausea, and vomiting after using a fuel-burning appliance or generator in an enclosed area. Because symptoms are nonspecific, carbon monoxide poisoning can easily be mistaken for a viral illness.

Clinical Features

Common manifestations include:

• Headache
• Nausea and vomiting
• Dizziness
• Fatigue
• Confusion
• Shortness of breath
• Chest pain
• Syncope or loss of consciousness

Severe poisoning can cause neurological injury, myocardial ischemia, arrhythmias, coma, or death.

A carboxyhemoglobin (COHb) level can help confirm exposure. Pulse oximetry may appear falsely normal because standard devices cannot reliably distinguish oxyhemoglobin from carboxyhemoglobin.

Mechanism of Action

Carbon monoxide binds to hemoglobin with much greater affinity than oxygen, forming carboxyhemoglobin. This reduces oxygen-carrying capacity and also impairs release of oxygen to tissues, resulting in cellular hypoxia.

Management

• Immediately remove the patient from the source of exposure.
• Administer high-concentration oxygen.
• Monitor neurological status, ECG, and cardiac biomarkers when appropriate.
• Hyperbaric oxygen therapy may be considered in severe poisoning, especially with loss of consciousness, persistent neurological abnormalities, significant cardiac involvement, severe acidosis, or pregnancy.
• Evaluate fire victims for possible simultaneous cyanide toxicity when severe lactic acidosis or cardiovascular collapse is present.

Key Points

• Headache is the most common symptom of CO poisoning.
• Multiple people with similar symptoms in the same enclosed environment should strongly raise suspicion.
• Standard pulse oximetry can be misleadingly normal.
• Cherry-red skin is uncommon and should not be relied upon for diagnosis.
• Patients with severe smoke exposure may have both carbon monoxide and cyanide poisoning.

Toxicology – Cyanide Poisoning

Source

Cyanide exposure can occur during smoke inhalation from structural fires, especially when materials such as wool, silk, plastics, insulation, or rubber burn. It may also be encountered in certain industrial settings, some foods or plant products, and rarely from prolonged nitroprusside therapy.

Typical Presentation

A patient exposed to heavy smoke or an occupational cyanide source may rapidly develop confusion, shortness of breath, chest discomfort, seizures, or cardiovascular collapse. Cyanide toxicity should be considered in severe smoke inhalation with unexplained lactic acidosis or sudden hemodynamic deterioration.

Clinical Features

Possible findings include:

• Headache
• Nausea and vomiting
• Altered mental status
• Dilated pupils
• Rapid breathing
• Tachycardia
• Early hypertension
• Later hypotension and respiratory depression
• Chest pain
• Seizures
• Cardiovascular collapse

Laboratory abnormalities may show:

• Severe lactic acidosis
• High anion gap metabolic acidosis
• Unusually high venous oxygen content because tissues cannot effectively extract oxygen

Mechanism of Action

Cyanide inhibits cytochrome c oxidase in the mitochondrial electron transport chain. This blocks aerobic cellular respiration, preventing tissues from using oxygen despite adequate oxygen delivery and causing rapid anaerobic metabolism and lactate accumulation.

Management

Treatment requires immediate supportive care:

• High-flow oxygen and airway support
• Cardiac and hemodynamic monitoring
• Aggressive management of seizures and shock
• Hydroxocobalamin is a preferred antidotal therapy because it binds cyanide to form a less toxic compound that can be eliminated
• Sodium thiosulfate may also be used to enhance conversion of cyanide to thiocyanate

Nitrite-based antidotes induce methemoglobinemia and are generally less desirable when carbon monoxide exposure is also suspected, as commonly occurs in fire victims.

Key Points

• Think of cyanide toxicity in patients with severe smoke inhalation plus cardiovascular collapse or marked lactic acidosis.
• Cyanide prevents cells from using oxygen rather than preventing oxygen from reaching the blood.
• Hydroxocobalamin is a major antidote used in suspected cyanide poisoning.
• A markedly elevated lactate level can serve as an important indirect clue.